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Goitre and Iodine Deficiency in Europe - A Review 
Extended Report of the Subcommittee for the Study of Endemic Goitre and Iodine 
Deficiency of the European Thyroid Association'2 
P. C . SCRIBA 
"The scientific community of the ETA has the obligation to contribute to the 
eradication of endemic goitre and iodine deficiency in Europe. With the available 
knowledge it seems an anachronism that endemic goitre in Europe still prevails." 
This was the conclusion of A. QUERIDO, the former chairman of the "ETA subcom-
mittee for the study of endemic goitre and iodine intake in Europe" in his 1981 re-
port (Pisa). The information so far collected by the subcommittee has been sum-
marized in four European maps (Fig. 1 - 4 ) , and in an additional table (Table 1). 
The list mentioned is unfortunately still incomplete with respect to some European 
countries. 
In general, epidemiologic information in a strict sense is scanty for most Euro-
pean countries. Vastly, there are just regional data available with relatively good in-
formation concerning the population sample studied (age, sex); however, it is fre-
quently difficult to conclude which part of the whole population of a given area is 
represented by the sample studied, what its relation to the other groups is, and 
which percentage of the total inhabitants of a country live in the areas studied. Un-
doubtedly, the methodological approach used for the review therefore deserves 
epidemiological criticisms. However, it was felt justified to present this imperfect 
information now, as even with the above limitations the data is alarming enough. 
(1) Members of the ETA Subcommittee: P. C. SCRIBA, Lübeck (chairman); C. BECKERS, Brussels; 
H. BÜRGI, Solothurn; F . ESCOBAR DEL REY, Madrid; M. GEMBICKI, Poznan; D. A. KOUTRAS, 
Athens; B. A. LAMBERG, Helsinki; P. LANGER, Bratislava; J . H. LAZARUS, Cardiff; A. QUERIDO, Lei-
den; C. THILLY, Brussels; R. VIGNERI, Catania. 
Further contributors: The ETA Subcommittee is grateful for personal communication of unpublish-
ed information and references cited as received from: N. CABASSA, Bolzano; A. COSTA, Torino; 
F . DELANGE, Brussels; E. DÜREN, Istanbul; J . W . F . ELTE, Leiden; G. FENZI, Pisa; H. FREY, Oslo; 
G. GALVAN Salzburg, R. GOEBEL, Graz; B. M. GOSLING, Leiden; R. GUTEKUNST, Lübeck; 
G. HENNEMANN, Rotterdam; F . A. HORSTER, Düsseldorf, R. ISLAMBEKOV, MOSCOW; M. H. JONCK-
HEER Brussels; P. LAMPERTICO, Milan; P. LAURBERG, Aarhus; E. LIMBERT, Lisboa; W . MENG, 
Greifswald; S. M. MILCU, Bucarest; T. MUNKNER, Kopenhagen; F . PETER, Budapest; A. PINCHERA, 
Pisa; J. PODOBA, Bratislava; R. RICCABONA, Innsbruck; B. SELZ, Solothurn; K. H. SJÖBERG, Oskars-
hamn; P. SMYTH, Dublin; L. G. SOBRINHO, Lisboa; G. SZILAGYI, Budapest; Z . SZYBINSKI, Krakow; 
I. URGANCIOGLOU, Istanbul; D. VAN DER HEIDE, Leiden; W . WALDHÄUSL, Vienna. 
(2) Presented in part at this meeting; official publication: The Lancet 7: 1289 - 1293 (1985). 
Table 1. Endemie goitre, iodine deficiency and prophylaxis in the individual European countries. 
Goitre prevalence 
on average, % 
0 = no endemic 
goitre 
epidemiological 
information 
Sample 
from population 
(year) 
PAHO 
goitre 
staging 
applied 
Information 
on 
regional 
goitre 
prevalence, 
% 
ioc 
ug per 
g creatinine 
or 24" 
[ ] = regional 
values 
Urinary 
line excretion 
Population 
sample 
Prophylaxis 
m = mandatory 
or > 90% 
v = voluntary 
n = none 
A Austria 3 recruits (1976) N = 47,576 (+) 
12; 
25 
students 
[65]; 
[47] 
N = 80; Northern 
Tyrol 
N = 293; Salzburg 
m 
B Belgium 1.8 recruits (1956) N = 54,237 - 3 [51] [50] 
N = 38; Brussels 
N = 178 
v ( ? ) 
BG Bulgaria 12 
(decreasing) 
whole population 
(1961); 
N > 65,000 
+ m 
CH Switzerland 0-B: 14 I: 1 
recruits (1983) 
N = 425 
Canton of Geneva 
+ 34 Bern; 
N = 2,916 
[93]; N = 770 Bern; whole 
population 
> 90% 
CS CSSR < 10 age dependent 
steady decline 
of RT-values 
> 2% of whole 
population + + 100 
adult women 
N = 2,484 m 
continued 
D Fed. Rep. Germany 15 recruits (1974) N — 5.4 mio. ( + ) + 
20-35 
South to 
North 
school children 
N = 1,945 
adults 
N = 5,678 
V 
DDR German Dem. Rep. 12 recruits (1978) N > 600,000 
( + ) + 25-37 whole country 16-50 y. 
N = 645 
m(?) 
DK Denmark (75 children (1970) N = 364,593; 
(7-17y) 
62 w h o l e c o u n t r y 17-20 v., N = 6000 n 
E 
Goitre prevalence 
on average, % 
0 = no endemic 
goitre 
pidemiological 
information 
Sample 
from population 
(year) 
PAHO 
goitre 
staging 
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Information 
on 
regional 
goitre 
prevalence, 
% 
ioc 
ug per 
g creatinine 
or 24h 
[ ] = regional 
values 
Urinary 
line excretion 
Population 
sample 
Prophvlaxis 
m = mandatory 
or > 90% 
v = voluntary 
n = none 
E Spain several areas of severe endemia, see text + 86 
Las Hurdes 
[16ug/l] school children N = 156; 
cretinism! 
V 
F France no information obtained - 10 [33] - V 
GB Great Britain no information obtained - 8 - - n(?) 
GR Greece see text - (+) 30 several 
areas afll. 
[20] V 
H Hungary < 11 school children (1965) 
N > 670,000 
+ still iodine deficient despite prophylaxis m 
I Italy Some heavily populated areas are free of endemic goitre, see text + 
l l - > 5 0 
several are-
als cf. 
BASCHIERI 
et al. 
[26] - [76] 
[51]-[19] mostly 
school children 
V 
IRL Ireland see text - 12, emi-grants 
6 8 — 12, 
school ch. 
II U — [151 N = 128 
school children 
V 
N Norway 0 - 1.5 [133] 100-300 N = 460 
V 
NL The Netherlands see text - + 2-13 [70]-[120] young adults m 
P Portugal see text - + 51 — 9.3 40 [12] 
[cretinism!] 
school children 
V 
E 
Goitre prevalence 
on average, % 
0 = no endemic 
goitre 
pidemiological 
information 
Sample 
from population 
(year) 
PAHO 
goitre 
staging 
applied 
Information 
on 
regional 
goitre 
prevalence, 
% 
ioc 
ug per 
g creatinine 
or 24h 
[ ] = regional 
values 
Urinary 
iine excretion 
Population 
sample 
Prophylaxis 
m = mandatory 
or > 90% 
v = voluntary 
n = none 
PL Poland see text - 31-50 adolescents, 
Cracow 
m 
R Romania no information obtained 60 Carpathian 
mount. 
iodine deficiency 
despite prophylaxis 
? 
S Sweden 0 - 0 (?) 200 - m 
SF Finland 0 + < 6 250 school ch. (1979) 
N = 1,275 
V 
> 90% 
SU Soviet Union no information obtained 27 
Taschkent 
- school children ? 
T Turkey see text - + Black Sea 
coast 
Anatolia 
[55] ? 
Y Yugoslavia no information obtained 25 Bosnia, 
Herzegovina 
(1959); 
N > 34,000 
m 
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Methodological Remarks 
The information provided in this report was extracted 
1. from the literature as cited and 
2 . from individual reports to the chairmen of the ETA goitre subcommittee in re-
sponse to repeated questionaires. 
The techniques for the study of endemic goitre have been established earlier. Ac-
cording to PAHO 1 9 7 4 (DUNN and MEDEIROS-NETO, 1974) , the goitre stages were 
defined stage 0-A to stage III. A note of caution appears necessary with regard to the 
assessment of the size of small goitres. Studies implying the technique of sono-
graphic volumetry have revealed, that approximately 4 . 3 % false positive results 
were obtained by experienced investigators when the diagnosis was based on pal-
pation when compared with a volume of 3 0 ml considered as the debatable upper 
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normal value for adults (GUTEKUNST et al., 1983) . The risk of overestimating small 
goitres particularly in school children has received attention in earlier reports 
(DUNN and MEDEIROS, 1974 ; SILINK and CERNY, 1 9 6 6 ) . These limitations for stag-
ing should be kept in mind, when surveys for endemic goitre are evaluated. 
In an area with a suspected goitre prevalence of more than 10%, examination of 
school children is recommended as a first step (DUNN and MEDEIROS-NETO, 1974) . 
However, when the goitre prevalence in the school population exceeds 10%, more 
than 1 % of the total population should be sampled. The latter procedure is particu-
larly recommended in areas with a recent increase of iodine supply, since the goitre 
prevalence can be remarkably high in elder age groups in such regions, when com-
pared with adolescents. If the goitre prevalence in the general population exceeds 
[ ] denotes regional values 
Fig 2. The urinary iodine excretion in Europe. See text and Table 1 for more detailed information. 
Values for Belgium und France were derived in part from LAGASSE et al. (1976). Values for Spain were 
given in ug/1, see text. 
Goitre and Iodine Deficiency in Europe - A Review. 2 5 
m: mandatory ( o r > 9 0 % ) 
v.- voluntary 
r : regional 
Fig. 3. Goitre prophylaxis in Europe. See text for more detailed information. 
1 0 % the urinary iodine excretion must be examined in specimens from 2 0 of every 
1 0 0 0 persons examined. School children of both sexes 1 0 - 1 4 years of age are the 
group recommended for this purpose (DUNN and MEDEIROS-NETO, 1974) . 
The daily urinary iodine excretion was considered equivalent to the iodine ex-
cretion per g creatinine in most European countries. However, in one Spanish area 
(ESCOBAR DEL REY et al. 1 9 8 1 ) protein malnutrition resulted in a decreased creati-
nine excretion per day, invalidating the jagl/g creatinine ratio. Nutritional factors 
for goitrogenesis other than iodine deficiency (INGENBLEEK et al., 1980 ; MATOVI-
NOVIC, 1 9 8 3 ) have not been included in this review on the European situation. 
It is obvious from the information presented in this review that most data do not 
meet the criteria mentioned above. Unfortunately, legal obstacles for epidemio-
logical research in some countries make the complete application of the "tech-
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niques for the study of endemic goitre" (DUNN and MEDEIROS-NETO, 1974) almost 
not feasible. Remarks about the information on individual European countries not 
available to the committee are therefore included in this report. 
B Endemic goiter only in areas depicted oc^> 
11 Endemic qoiter in the country as a whole 
Fig. 4. Current status of effectiveness of goitre prophylaxis in Europe. 
Survey Concerning the Situation in Individual European Countries 
Some reviews relevant to endemic goitre and iodine deficiency are cited since 
they are referred to repeatedly in this report (KELLY and SNEDDEN, 1 9 6 0 ; KOUTRAS, 
1980 ; LANGER , 1980 ; BECKERS and DELANGE, 1980) . PFLÜGER ( 1 9 3 7 ) published 
two maps depicting the goitre distribution in central Europe, one of his own and 
one drawn by H . BIRCHER already in 1 8 8 3 . The European maps presented in this 
review show the global information on goitre prevalence (Fig. 1), urinary iodine 
excretion (Fig. 2) , and iodine prophylaxis (Fig. 3). A characterization of the current 
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status of the efficacy of goitre prevention is given in the conclusions paragraph 
(Fig. 4) . The European countries are discussed below alphabetically: 
A = Austria: Goitre prevalence in army recruits was recently reported to be 
3 . 3 % (STEINER and ZIMMERMANN, 1978) . However, after 1 7 years of man-
datory ( 9 0 % ) iodine prophylaxis in Austria, RICCABONA et al. ( 1 9 8 1 ) re-
ported a decrease of the goitre prevalence from 5 0 to 3 5 % in the popula-
tion as a whole and from 4 5 . 9 % to 1 2 % in school children of three towns in 
Northern Tyrol. The authors therefore suggest raising the content of po-
tassium iodide in the salt from 1 0 to 2 0 mg per kg. Currently, the urinary 
iodine excretion is 6 5 . 3 p,g/g creatinine in this area. -GRUBECK-LOEBEN-
STEIN et al. ( 1 9 8 2 ) observed a selected group of 8 0 patients with "ordinary" 
goitre in Vienna with only 4 8 % of the patients having an iodine excretion 
of less than 7 0 jug per 2 4 h. - A further appeal for an increased iodine con-
tent of the table salt was published by GALVAN et al. ( 1 9 8 2 ) after demon-
stration of an average urinary iodine excretion of 4 6 . 6 jig per g creatinine 
in 2 9 3 students in Salzburg; 7 3 of these students had a palpable goitre. 
Likewise, GOEBEL et al. ( 1 9 8 3 ) reported a decrease of the mean radio-
iodine uptake rates from 5 2 . 4 % in 1 9 7 2 to 3 0 . 5 % in 1 9 8 1 for Graz, where 
the mean urinary iodine excretion is currently 5 3 . 3 jig/g creatinine. 
AL = Albania: No information was obtained. 
B = Belgium: The population has a marginally low iodine intake (BECKERS et 
al., 1962; DE CROMBRUGGHE et al., 1 9 6 3 ; DELANGE et a l , 1 9 7 8 ; KOUTRAS, 
1 9 8 0 ) . The study of 5 4 , 2 3 7 males aged 1 8 years (recruits to the army) 
showed that the mean prevalence of goitre (criteria not defined) was 1.8%. 
It increased from the north-western to the south-eastern parts of the coun-
try (BRULL and DEWART, 1956 ) . More recent epidemiological data for the 
country have not been forwarded. 
In 1 8 normal adults, the mean urinary excretion of iodine was found to be 
6 5 . 6 ± 5 . 1 0 |ig/day (DE CROMBRUGGHE et al., 1964) , a finding later con-
firmed in 1 2 adults by DELANGE and ERMANS ( 1 9 6 7 ) , who found a mean 
urinary iodine of 5 8 . 8 ± 6.1 jag/d. Studies on the seasonal variation of 
stable iodine in non-toxic goitre performed more recently by JONCKHEER 
et al. ( 1 9 8 2 ) in the Brussels area indicate a mean excretion of 5 0 jigl/g 
creatinine. The first collaborative report on iodine deficiency in Europe 
was published only in abstract form (THILLY et al., 1973) . Table 2 showes 
the 2 4 h radioiodine-uptake in some European countries; the mean value 
was 4 6 % for Europe as a whole. This type of information permitted the 
authors to calculate regional mean iodine intake values according to the 
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Table 2. Synoptic survey of 24 h n iI thyroidal uptake values for seven countries. The mean (± SEM), the 
mode and the median were reported by LAGASSE et al. (1976). 
Country-
Number 
of 
subjects 
Number 
of 
centers 
24 h m I thyroidal uptake 
mean ± SEM mode median 
Switzerland 162 2 32.6 ± 0.8 28 32 
The Netherlands 411 3 39.9 ± 0.5 40 37 
France 938 8 40.9 ± 0.6 38 38 
Italy 1510 10 42.2 ± 0.4 40 37 
Belgium 1232 14 47.0 ± 0.5 44 46 
Luxembourg 69 1 52.3 ± 1.5 55 53 
Germany 1055 7 59.6 ± 0.5 62 60 
Total 5377 45 46.2 ± 0.2 40 42 
method of ODDIE et al. (1970). The latter values have been transformed 
into urinary iodine values (see Fig. 2) by multiplication with f = 0.66 ac-
cording to HABERMANN et al. (1975). 
Preliminary observations in 29 adolescents, 8-15 years of age indicated a 
urinary excretion of iodine of 42 ± 4.5 |ig/d. In this group, the thyroid 
clearance rate of iodine was 27 ± 3.4 ml/min, and with a plasma-
inorganic iodine of 1.1 ± 0.14 jig/1, the absolute iodine uptake was 
37 ± 4.7 jLtgI/24 h (MALVAUX et al., 1965). This finding was confirmed by 
DELANGE and ERMANS (1967) who found in adolescents, 10-15 years of 
age (n = 23) a 24 h urinary excretion of iodine of 43.9 ± 5.7jig/d. BECKERS 
and NOEL (1972) observed the urinary iodine excretion in 483 healthy 
school children and adolescents. Minimal values typical of iodine defi-
ciency were found among subjects aged 9-10 and 13-15 years. Iodine ba-
lance studies in 26 nongoitrous children and adolescents gave a mean 
iodine intake of 32 ± 1.94 jig/d (MALVAUX et al., 1969). All these results 
clearly stress the insufficient iodine intake in the Belgian population. 
BG = Bulgaria: A survey of 1 million school children in 1957 revealed a goitre 
prevalence of 19.2%. Thereafter, a reduction of the regional goitre prev-
alence from 55 to 12% was reported. No endemic goitre is now observed 
below 15 years of age (LANGER, 1980). 20 mg potassium iodide per kg salt 
are used. 
C H = Switzerland: Goitre prevalence in 1975 increased with age: 20% (including 
stage 0-B) in the age range of 20-39 years, and 60% between 60 and 79 
years in general hospital patients. The potassium iodide content of salt 
was raised from 5 mg/kg to 10 mg in 1962 and to 20 mg/kg in 1980. The 
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high goitre prevalence in the elderly is probably due to the fact that they 
suffered from iodine deficiency before the salt was adequately iodinated 
(STECK et al., 1972; GEISER et al., 1978; SCHMID et a l , 1980; BÜRGI et a l , 
1982; EBERHARD et al., 1983). Among 425 men aged 19 and examined for 
entry into the army, goitre (all stage I) was found in 4 (1 %) in 1983 (B. SELZ 
and H. BÜRGI, personal communication). 
CS = Czechoslovakia: A prevalence of goitre of 50% (m) and 70% (f) was ob-
served in more than 370.000 persons examined between 1947 and 1953 
(LANGER, 1980), before the introduction of iodine prophylaxis. Correla-
tion to low iodine excretion and to thiocyanate from brassica (PODOBA 
and LANGER, 1964), respectively was shown. Detailed data on the prev-
alence of all and nodular goitres and of different sizes of goitres in the men 
and women according to old districts during the years 1949 to 1953 have 
been published (PODOBA, 1962; PODOBA et al., 1970). 
Iodine prophylaxis was started in 1947 in some selected areas only, but 
since 1953 it was introduced in the whole territory. At that time, the con-
tent of potassium iodide was 12 mg/kg, but in some areas 25 mg/kg were 
used. Since 1965 the level of 25 mg/kg was used in the whole territory. It is 
being considered to increase the level up to 35 mg/kg after 1985. - Fol-
low-up studies in 100 000 subjects showed urinary iodine values in-
creasing to 100 jig per 24 h and age-dependent decreases of goitre preva-
lence reported as RT-value, which stands for relative thyroid weight given 
in percent with RT = 100 being normal (SILINK and CERNY, 1966). The 
iodine prophylaxis was interrupted for almost 7 years in 2 districts, which 
clearly showed an increase of radioiodine uptake by the thyroid, an in-
crease of TSH in serum, and a decrease of urinary excretion of iodine from 
109.0 to 33.3 mg/24 h (district BK) and of PBI in serum (PODOBA and STU-
KOVSKY, 1972; PODOBA, 1975; PODOBA and REISENAUER, 1982). 
D = Federal Republic of Germany: Military conscripts (5.4 million) have an 
average goitre prevalence of 15%; 85% of the goitrous have goitre stage I 
(HORSTER et al., 1975). Iodine deficiency (HABERMANN et a l , 1975) was 
documented by chemical analysis in urines of school children and by cal-
culation from radioiodine uptake of adults after ODDIE et al. (1970). Potas-
sium iodine was not sufficiently stable in iodized salts from several Euro-
pean countries (HABERMANN et al., 1978). The iodination of the salt to be 
used on a voluntary basis was altered in 1981, so that potassium iodate is 
added to give an iodine content of 20 mg per kg salt (SCRIBA, 1981). 
DDR = German Democratic Republic: An average goitre prevalence of 12% was 
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found in recruits. Low urinary iodine excretion was observed in school 
children. Mandatory iodine prophylaxis will probably be introduced soon 
(MENG et al., 1981). 
DK = Denmark: A nation-wide screening of 6000 young men revealed a mean 
urinary iodine excretion of 64 |ig/24 h, but was only published in abstract 
form (MUNKNER, 1969). The values were higher in Seeland (68-139) than 
in Jutland (41-68 |ig/24h). According to the ETA-questionaire 1981 (T. 
MUNKNER) and to personal communication (P. LAURBERG) a committee 
under the Danish Health Department concluded from unpublished data 
on goitre prevalence in school children, that iodine prophylaxis was not 
necessary. Further information is lacking (KOUTRAS, 1980). 
E = Spain: There are some areas with endemic goitre, according to older re-
ports (PFLÜGER, 1937; KOUTRAS, 1980). - All the boys and girls (N = 156; 
6 - 1 4 y) regularly attending school in three villages from an area in Spain 
known as Las Hurdes were studied (ESCOBAR DEL REY et al., 1981) with re-
spect to thyroid size, body weight and height. The same survey was carried 
out in 354 school children from Madrid. Goitre prevalence was very high, 
the overall frequency being 86% in Las Hurdes. The concentration of 
iodine in the urine was 20 fxg/1 in 71% of the school children. The concen-
tration of creatinine in the urine was also half of that found in children 
from Madrid, and the daily creatinine excretion in children from Las Hur-
des was lower than expected from their body weight. Therefore, urinary 
iodine was not related to g creatinine excretion. Somatic development, as 
measured by height and weight, was retarded markedly, both as compared 
to the Madrid reference group and to international charts. Serum T4 was 
less than 78 nmol/1 (6 ]ig/dl) in 46% of the children from Las Hurdes, and 
serum TSH greater than 7.5 mU/1 in 40%. A relatively low stature (below 
the 10th percentile) was associated with either a low serum T4, an elevated 
serum TSH, or both in 30% of the children. These results indicate that the 
persistence of endemic goitre in Las Hurdes is of great significance, and 
that there is a continuing risk of the birth of cretins. - Meanwhile, injec-
tions of iodized oil have been administered in this area (SANCHEZ-
FRANCO etal. , 1983). 
The following areas of endemic goitre (PAHO-classification) and severe 
iodine deficiency have been identified meanwhile and are currently being 
investigated: Several hundreds of school children from further villages of 
the 3 provinces of Cäceres, Salamanca and Guadalajara have been studied 
by F. ESCOBAR DEL REY et al. (personal communication); thousands of 
school children were studied in all provinces of Andalucia (Sevilla, Cadiz, 
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Huelva, Cordoba, Granada, Almeria, Jaen), where goitre grade 0-B + I 
was found in 17.4 to 45.7% of the school children of the villages; in this 
area, urinary iodine was below 60 (ig/1 in 33.1 to 86% (principal investiga-
tor: S. DURAN-GARCIA). Iodine deficiency and endemic goitre was also 
shown in 2500 persons equivalent to 0.6% of the population of villages of 
the provinces of Cataluna (main investigator L. SERRA I. MAJEM), and in 
villages of Galicia, where goitre incidence was 79%, with 85% excreting 
less than 25 jig iodine per liter urine (R. TOJO). - Recently, iodized salt (60 
mg Kl/kg) available on a voluntary basis was introduced in Spain. 
F = France: Endemic goitre was reported from the Pyrenees (KOUTRAS, 1980). 
According to the elder literature (PFLÜGER, 1937), there were several areas 
of endemic goitre in France. 
GB = Great Britain: The regional prevalence reported does not permit epi-
demiological conclusions (KOUTRAS, 1980; TUNBRIDGE, 1977). According 
to the elder literature (PFLÜGER, 1937), there were several areas of en-
demic goitre in Great Britain (Derbyshire neck). PHILLIPS et al. (1983) 
published a map depicting areas of England and Wales, where endemic 
goitre has been prevalent in the past. The authors showed, that the distri-
bution of mortality from thyrotoxicosis among women in England and 
Wales during 1968 - 78 correlates with the previous prevalence of end-
emic goitre. The average British diet was calculated to provide 323 jigl/ 
day. Milk was be most variable as well as the most important individual 
source of iodine. Summer milk samples contained 70 ^ig/kg and winter 
milk 370 |ig/kg on average (WENLOCK et al., 1982). 
GR = Greece: The regional prevalence of goitre and iodine deficiency was re-
peatedly reported (KOUTRAS, 1980). Endemic goitre is still prevalent in 
Greece (D. A. KOUTRAS, personal communication). Although the exact 
prevalence in the whole country is not known, sample studies in many re-
gions as well as the experience of the thyroid centers permit the construc-
tion of a map (Fig. 4). In some villages the entire population has been ex-
amined, in others as well as in Athens only the school children. In the en-
demic villages fully studied, prevalence rates up to 50% have been found. 
An average of 30% for the endemic areas seems to be a good guess. Athens 
and the big cities are relatively spared, non-endemic. 
In Greece, the urinary excretion of iodine in the endemic areas ranges 
from 20 to 40 jxg/g creatinine. In Athens, the urinary iodine excretion rose 
from 44.9 [ig/d (MALAMOS et al., 1966) to 94.5 jug/g creatinine (KOUTRAS et 
al. 1982). - Iodized salt is used (40 mg Kl/kg) on a voluntary basis. Since it 
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is more expensive, it is used more by the well to do Athenians who are not 
iodine deficient, than by the poor villagers who are. 
H = Hungary: A decrease of goitre prevalence from 32 to 11% in school boys 
from some iodine deficiency areas was reported (G. SZILAGY, ETA-ques-
tionaire, 1981). The iodine content of the salt was subsequently increased. 
However, the supply of iodized salt is somewhat irregular (F. PETER, per-
sonal communication) and from data in 60 newborns it was deduced, that 
iodine deficiency may still prevail. 
I = Italy: The regional prevalence of goitre and iodine deficiency has been ex-
tensively studied (BASCHIERI et al. 1978; DELANGE et al., 1978; COSTA and 
MORTARA, 1981;SQUATRiT0etaL, 1981; SAVAet al., 1982; VIGNERI et al., 
1982). Further goitrogenic mechanisms have been considered. Prophy-
laxis was first introduced in the valley D'Aosta. Iodized salt is now avail-
able on a voluntary basis. Iodized salt consumption, however, is very li-
mited even in areas of severe goitre endemia. Extensive regional informa-
tion on iodine content of water, kitchen-salt and foods, the urinary iodine 
output, and goitre prevalence in school children has been published. 
A study has been carried out in Sicily where an endemic goitre area involv-
ing more than 300.000 inhabitants has been described. Goitre prevalence, 
evaluated among more than 25.000 school children in this area of Sicily, 
ranges from 25% to 80% (DELANGE et al., 1978; SAVA et al., 1982; 
F. TRIMARCHI and A. JANNI, personal communication, 1984). Urinary 
iodine excretion averages 90-120 jig/24 h in non-endemic areas of Sicily, 
while it is as low as 18 jig/24 h in the most severe endemic goitre area. En-
demic cretinism has been observed in this area (SQUATRITO et al., 1981).-
A prophylactic program through water iodination has been carried out in 
Troina (Sicily) resulting in a nearly complete goitre eradication in 4 years 
(VIGNERI et al., 1982). - Further endemic goitre areas have been described 
in Lazio and Calabria (DE LUCA et al., 1966): ,3,I thyroid uptake at 24 h was 
as high as 75 - 90% in these areas. 
In 1982, the prevalence of goitre (WHO IB-III) was 23.7 ± 14.2% 
(9.3-37.9%) among 3109 school children of Alto Adige, mean altitude 
1106.4 m/sml; regional values of the urinary iodine excretion varied be-
tween 4.57 (!) and 18.5 \ig per g creatinine (N.CABASSA, F. FRANZELLIN, 
personal communication). - A detailed survey of current endemic goitre 
areas in sanitary districts of Tuscany was provided by G. FENZI and A. 
PINCHERA. In some districts, the goitre prevalence was as high as 63% in 
school children and 83% in adults. In the Appenin Mountain district 4, 
where the mean urinary iodine excretion was 44.2 jig per g creatinine, io-
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dized salt (KI, 1 2 0 mg/kg) is now distributed on a voluntary basis (DOVERI 
et al., 1 9 8 1 ; BARTALENA et a l , 1982) . 
The survey on pathology of the thyroid gland, promoted by the Italian Di-
vision of the International Academy of Pathology in the period 
1 9 7 7 - 1 9 7 9 , through the active participation of about 1 6 0 pathologists 
working in the Universities and Hospitals of 1 6 Italian Regions covered 
about 8 2 % of the Italian population (LAMPERTICO 1982 ; the same issue 
contains detailed regional reports). 3 7 . 0 1 6 partial or total thyroidectomies 
performed represent 1 .66% of all the surgical specimens histologically ex-
amined with an average incidence of 2 8 surgical procedures on the thyroid 
every year for 1 0 0 . 0 0 0 people, with great regional variability (from 5.7 in 
Umbria to 4 8 . 4 in Marche). The male/female ratio was 1/4.8 for benign 
disease. The age distribution was stated in 2 1 . 1 3 1 benign and 2 . 1 2 5 malig-
nant conditions. 
In summary, endemic goitre is widespread all over Italy, especially in 
most mountain areas, while big cities and some heavily populated areas 
are apparently free of endemic goitre (Fig. 4 ) . 
IRL = Irland: A goitre prevalence of 2 7 % and 1 2 % was reported in female and 
male emigrants, respectively (GREENWALD, 1 9 7 5 ; KOUTRAS, 1980) . The 
Tipperary survey revealed an area of endemic goitre ( 6 8 % among 7 0 0 
school children) due to iodine deficiency, with an iodine intake as low as 
1 1 - 1 5 jig per day in 1 9 4 6 . Goitre prevalence was reduced within 3 1/2 
years to 1 2 % by treatment with iodine ( 2 5 0 0 jig/d) (O'DONOVAN, 1 9 5 0 ) . 
Iodized salt ( 4 2 tons) constitutes 1.2% of total salt sales in Ireland, 3 4 tons 
being sold in S. Tipperary and N. Cork (P. SMYTH, personal communica-
tion). No further information has been obtained. 
IS = Iceland: There is no endemic goitre (KOUTRAS, 1980) . No further informa-
tion is available. 
N = Norway: Modum, a Norwegian community, where endemic goitre and 
iodine deficiency were common before the last war, was reexamined in 
1 9 7 7 (FREY et al., 1 9 8 1 ) . There is obviously no longer any endemic goitre 
in Norway. The urinary iodine excretion varies in women und men be-
tween 1 6 5 - 3 6 4 (ig per day. The high iodine intake is mainly due to feeding 
of cows with seaweed, whereas iodized salt ( 5 jig KI per kg) contributes 
only neglegable amounts of iodine (FREY et al., 1974) . 
NL = The Netherlands: There is some regional endemic goitre left in The Ne-
therlands (WHO grade I and II, disregarding grade 0-B) . All salt used for 
baking bread has to be iodized. Iodine intake was considered to be inade-
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quate in Doetinchem (A . QUERIDO, personal communication). The report 
No. 78 of the Ministry of Health (NL) published in 1981 and forwarded by 
G . HENNEMANN, proposed that struma prophylaxis be improved by rai-
sing the KI content of bread salt, (at present 46 mg per kg), to 60 mg, so that 
one slice of bread would contain 20 jig iodine. It also proposes making the 
addition of KI to household salt compulsory, at a level of 26.2 mg per kg 
salt, so that 1 g salt would contain 20 jig iodine. Those who consume four 
slices of bread and 4 g household salt per day (the nowadays reduced aver-
age per capita consumption) would obtain a daily iodine supplement of 
160 For the vast majority of the population this will mean a daily 
iodine intake in the optimal zone of between 150 and 300 jig; more modest 
eaters will remain outside the danger zone through an average daily intake 
of 100 to 150 |ng iodine, whilst those who consume large amounts of bread 
and household salt, and thus have an intake of ca. 400 to 500 jig iodine per 
day, should suffer no harmful effects. 
The most recent survey in Leiden and Doetinchem, western and eastern 
parts of the Netherlands, showed an increase of the urinary iodine excre-
tion and decrease of the goitre prevalence, more clearly for grade I than for 
grade 0-B, which was still found in 26% of the female school children in 
Doetinchem (J. W. F. ELTE, D. VAN DER HEIDE, B. M. GOSLINGS, A. QUE-
RIDO, personal communication, 1983). 
P = Portugal: Most of the population of Portugal lives near the coast, where 
there is no endemic goitre (L . G . SOBRINHO, E. LIMBERT, personal commu-
nication). However, several regions of the interior are severely affected. 
Some regions were studied locally in detail. In one region of the district of 
Castelo Branco nearly 16,000 school children and adults were studied in 
1963-1966. An average of 51% of the school children had goitre. Of the 
adult males 35% had grade II goitre and 2% grade III goitre. Prophylaxis 
with iodized salt (20 mg KI per kg) started in 1971, which reduced the goi-
tre prevalence in school children to 9.3% by 1977 (LOPES DE OLIVERA et 
al., 1983). An upsurge of Jod-Basedows was detected in the ensuing years 
(SOBRINHO et al., 1977). - In another region, also in the district of Castelo 
Branco, the prevalence of goitre in school children approached 40% 
(1978). Here, the mean urinary iodine from school children lacking iodine 
prophylaxis was 12 jig/g creatinine. Two further regions, Baixo Alentejo 
and Algarve and Portalegre respectively were recently shown to house goi-
tre endemia up to 54% locally and some endemic cretinism! 
PL = Poland: A goitre prevalence of 20 - 40% in adolescents was reported 
(Z. SZYBINSKI, ETA-Questionaire, 1981), despite the use of 8 mg 
potassium iodide per kg salt (LANGER, 1980). After 20 years of prophylaxis 
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with currently 1 2 mg KI per kg salt, the goitre prevalence is still between 
3 1 and 5 0 % in southern parts of Poland as the Carpathian Mountains and 
Cracow. In addition, the eastern parts of Poland appear to be heavily 
afflicted in a map published (FALKIEWICZ and PACYNSKI, 1 9 6 7 ) . 
R = Romania: A regional prevalence of more than 6 0 % is reported for the 
Carpathian mountains (LANGER, 1980) . Antiendemic centers have been 
organized in all endemic regions during the 1 9 4 9 - 1 9 7 8 period (S. M. 
MILCU, personal communication). Iodized salt for the population and, in 
addition, iodinated tablets for school children and pregnant women, have 
been used. Unfortunately, the results of this campaign have only been 
published in Romanian (MILCU, 1 9 5 7 ) . More recent information is des-
irable. 
S = Sweden: There is probably no longer endemic goitre in Sweden 
(JOHNSSON, 1 9 6 5 , KOUTRAS, 1980) . All table salt is iodized ( 5 0 mg/kg) for 
more than 1 0 years, starting with 1 0 mg/kg in 1 9 3 0 and raising in iodine 
content to 2 0 mg/kg in 1 9 4 0 . The same salt is used for commercial baby 
diets. All foods used for animals are iodized (R. GUTEKUNST, personal 
communication). Further information is lacking. 
SF = Finland: Endemic goitre is obviously disappearing steadily. There is vo-
luntary but highly distributed use of iodized salt. Milk products are shown 
as additional iodine sources (LAMBERG et al., 1 9 8 1 ; LAMBERG et al., 1 9 8 2 ) . 
The average dietary iodine intake is now 3 4 0 jig/d/person (VARO et al., 
1 9 8 2 ) . Earlier reports of goitrogens in the milk have to be remembered 
(KOUTRAS, 1980) . 
SU = Soviet Union: No information about western parts of the Soviet Union has 
been obtained. An endemic area of Usbekistan with iodine deficiency 
goitre was described by ISLAMBEKOV et al. ( 1 9 7 3 ) ; prophylaxis is perfor-
med in this area with 1 mg iodine per day. 
TR = Turkey: Endemic goitre is a problem on the Black Sea shore and in the in-
ner parts of eastern und western Anatolia (ESER, 1966) . In some provinces 
such as Bolu, Bursa, Isparta, Kastamonu, Rize and Trabzon, goitre preval-
ence is over 15%, in many provinces such as Adiyaman, Artvin, Bilecik, 
Bingöl, Burdur, Canakkale, Denizli, Eskisehir, Gümüshane, Izmir, Kars, 
Konya, Kütahya, Malatya, Mardin, Mus, Sakarya, Samsun, Sinop, Sivas, 
Tokat, Yozgat and Zonguldak goitre prevalence is 5 - 15%. Those are pre-
liminary results; however, a nation-wide detailed investigation on the pre-
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valence of endemic goitre in Turkey is under progress. Screening and grad-
ing of goitre by neck palpation has started, beginning from regions with 
high prevalence of goitre. Urinary iodine excretion will also be determined 
in those regions (URGANCIOGLU et al., 1 9 8 2 ) . The information given in 
Fig. 4 was taken from a preliminary map provided by I. URGANCIOGLU 
and E. DÜREN. 
YU = Yugoslavia: A persisting regional prevalence of endemic goitre of up to 
2 5 % and the mandatory use of iodized salt ( 1 0 mg Kl/kg) since 1 9 5 6 were 
reported (LANGER, 1980 ; MATOVINOVIC, 1 9 8 3 ) . The failure completely to 
eradicate goitre was ascribed to defects in the iodization techniques and/or 
loss of iodine from the salt (MATOVINOVIC, 1983 ) . Further information has 
not been obtained. 
Though outside of the direct scope of this review, it should be noted, that there 
are regions of severe iodine deficiency and endemic goitre in North Algeria 
(BACHTARZI and BENMILOUD, 1983) . 
Tentative Conclusions 
Even when keeping in mind some limitations of this review, which are due to in-
completeness of the information obtained, the results of the inquiries performed by 
the ETA Subcommittee for the Study of Endemic Goitre and Iodine Intake in Eu-
rope already permit some conclusions (Fig. 4) : 
1. There are some European countries where either endemic goitre used to be pre-
valent within the country as a whole or where areas of endemic goitre (and creti-
nism) were formerly well described. Iodine prophylaxis either mandatory or 
voluntary, but accepted by more than 9 0 % of the population was introduced in 
these countries but had and still has to be intensified in some cases, since it was 
shown to be formerly insufficient. Nevertheless, eradication of endemic creti-
nism and a marked reduction of goitre prevalence have been reported particu-
larly for the younger age groups. This description would probably apply to Aus-
tria (?), Bulgaria, Switzerland, CSSR, Hungary (?), The Netherlands (?), and Fin-
land. 
Other countries with sufficient iodine intake and probably no endemic goitre 
are Great Britain (?), Ireland (?), Norway and Sweden. - A third group of coun-
tries have documented borderline low or insufficient alimentary iodine intake 
but fail to report even regional endemic goitre as Denmark and Belgium (?). 
It is notable that the eradication of goitre has not only been achieved through 
iodine prophylaxis but in some countries is also due to a change in alimentary 
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habits, e.g. feeding of seaweed to cows and use of iodine containing disinfectants 
in dairy hygiene. This resembles the situation in the United States and in Tas-
mania (FREY et a l , 1974 ; ADAMS et al., 1 9 7 5 ; STEWART and VIDOR, 1 9 7 6 ; LAM-
BERG et a l , 1982) . 
In fact, a gradual increase of the supply of iodine for goitre prophylaxis over de-
cades was applied in several European countries as Austria, Czechoslovakia, 
The Netherlands, Sweden and Switzerland. This slow increase of alimentary 
iodine may help to minimize iodine induced thyrotoxicosis (cf. HALL and KÖB-
BERLING, 1984) and possibly thyroid antoantibody development, respectively 
(BOUKIS et al., 1983) . 
In the group of formerly iodine deficient countries some open questions and 
continuing tasks are left (DUNN and MEDEIROS-NETO , 1974) which include 
- monitoring of iodine prophylaxis, which is to be continued with repetition of 
goitre prevalence surveys and monitoring of the urinary iodine excretion, 
- studies on prevalence of residual goitre and goitrogenic mechanisms other 
than iodine deficiency, and 
- longitudinal studies on the question, whether the sequelae of iodine defi-
ciency and endemic goitre, as nodular goitre in the elder age group, or in-
creased frequency of single toxic autonomous adenomas and disseminated 
autonomy will gradually subside. 
All efforts aiming at these problems have to be recommended for this group of 
countries. 
2 . There are some European countries where endemic goitre is still prevalent, 
when the country is regarded as a whole. The two parts of Germany, Federal Re-
public of Germany and German Democratic Republic, have convincingly de-
monstrated endemic goitre and iodine deficiency. Other countries may have to 
be added. An effective general iodine prophylaxis has to be recommended 
strongly for these countries. 
3 . There are some European countries, where only regional prevalence of endemic 
goitre and iodine deficiency have been documented, the remainder of the coun-
try being free of endemic goitre. The information as received up to now does not 
always allow conclusions as to the epidemiological situation within the country 
as a whole. Therefore, either general iodine prophylaxis or regional measures 
are an alternative for these countries. The list of such countries may have to in-
clude Spain, France, Greece, Italy, Portugal, Poland (?), Romania, Turkey, and 
Yugoslavia. 
Possibly, one will have to add some of the following countries: Belgium, Den-
mark (?), Great Britain (?), Ireland (?) and the Soviet Union (?). 
Further epidemiological studies are strongly recommended for some of these 
countries (Table 1), since either general or regional iodine prophylaxis appears 
desirable. 
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The information provided by this report pertains to goitre prevalence, urinary 
iodine excretion surveys and prophylactic measures only. Further support for the 
ETA's effort aiming at the eradication of iodine deficiency and endemic goitre can 
probably be derived from other data: 
1. The study of the iodine supply of the newborn in Europe (ESPE and ETA sub-
committees, 1982; cf. DELANGE et a l , 1979; HEIDEMANN et al., 1984) provided 
evidence for iodine deficiency in some European centers, particularly in Ger-
many. The consequences described are e.g. transient effects on thyroid function 
(increased frequency of elevated TSH values in screening programmes for con-
genital hypothyroidism) and increased susceptibility to toxic effects of acute 
iodine loads, as goitre and transient hypothyroidism. The increased frequency 
of elevated TSH in neonatal screening programmes may be considered as a sen-
sitive parameter for iodine deficiency, indicating changes in iodine supply at the 
earliest feasible interval (VAN THIEL et al., 1982). 
2. Hyperthyroidism is more frequently due to single toxic adenoma or dissemi-
nated or multifocal autonomy including non-immunogenic toxic nodular goitre 
as compared with Graves' disease in iodine deficiency areas, where a particular 
susceptibility for hyperthyroidism induced by excess iodine loads was reported 
(ADAMS et a l , 1975; STEWART and VIDOR, 1976; EMRICH et al., 1982). For in-
stance, 50.8% and 31.6% of the thyrotoxic patients from Munich referred to sur-
gery (N = 625) and seen in the Medical Department (N = 734), respectively had 
a single autonomous adenoma as compared to 23% and 28.4% with exophthal-
mic Graves' disease (HEBERER et al., 1978; LEISNER et al., 1980).These figures 
are way above data reported for the United States and Canada (WILLIAMS et a l , 
1984). Recently, BELFIORE et al. (1983) reported an increased frequency of auto-
nomously functioning thyroid nodules in another iodine deficiency area. 
ADAMS et al. (1975) quote H.D. PURVES (1974) reporting a finally decreased fre-
quency of toxic adenomas some years after the introduction of iodine prophy-
laxis in New Zealand. 
There is an enormous amount of money spent for diagnosis and treatment of thy-
roid diseases by Public Health systems or insurance companies in our countries. 
380 million DM were spent for out-patient diagnosis and medical treatment be-
cause of thyroid disorders in 1979 in the Federal Republic of Germany (PFANNEN-
STIEL and HÖRSTER, 1982). This amount of money is chiefly spent for endemic 
goitre and its sequelae. It may help government authorities to make up their minds 
about iodine prophylaxis, when the public becomes aware of these figures, simple 
goitre being "the easiest of all known diseases to prevent" (MATOVINOVIC, 1983). 
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